Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C

Clin Infect Dis. 2011 Dec;53(12):1291-5. doi: 10.1093/cid/cir665. Epub 2011 Oct 25.

Abstract

The role of rs1127354/rs7270101 alleles at the inosine triphosphatase (ITPA) gene on ribavirin-induced anemia was assessed in 74 patients with hepatitis C virus and human immunodeficiency virus coinfection. Anemia developed in 80% of patients with normal ITPA activity compared with 33% of those with reduced ITPA activity. In contrast, ITPA variants did not influence sustained virological response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anemia / chemically induced*
  • Anemia / epidemiology
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects*
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Incidence
  • Inosine Triphosphatase
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Pyrophosphatases / genetics*
  • Pyrophosphatases / metabolism
  • Ribavirin / administration & dosage
  • Ribavirin / adverse effects*
  • Risk Assessment

Substances

  • Antiviral Agents
  • Ribavirin
  • Pyrophosphatases